Biotechnology (39) | Modification Agreements (39)

Browse by Company

Recent Contracts

Contract modification No (CHIMERIX INC, Filed With SEC on May 6, 2021)
Modification No. 6, effective March 24, 2021, to Task Order 75A50120F33007 (Emergent BioSolutions Inc., Filed With SEC on April 30, 2021)
Modification No. 5, effective February 22, 2021, to Task Order 75A50120F33007 (Emergent BioSolutions Inc., Filed With SEC on April 30, 2021)
Modification No. 02 to Undefinitized Project Agreement No. 01, entered into September 10, 2020, between the Company and Advanced Technology International (NOVAVAX INC, Filed With SEC on March 1, 2021)
Modification No. 03 to Undefinitized Project Agreement No. 01, entered into September 18, 2020, between the Company and Advanced Technology International (NOVAVAX INC, Filed With SEC on March 1, 2021)
Modification No. 04 to Undefinitized Project Agreement No. 01, entered into December 23, 2020, between the Company and Advanced Technology International (NOVAVAX INC, Filed With SEC on March 1, 2021)
Modification No. 05 to Undefinitized Project Agreement No. 01, dated January 12, 2021, between the Company and Advanced Technology International (NOVAVAX INC, Filed With SEC on March 1, 2021)
Modification No. 06 to Undefinitized Project Agreement No. 01, entered into January 19, 2021, between the Company and Advanced Technology International (NOVAVAX INC, Filed With SEC on March 1, 2021)
Amendment of Solicitation/Modification of Contract, Modification No. 2, entered into December 1, 2020, between the Company and the U.S. Department of Defense Joint Program... (NOVAVAX INC, Filed With SEC on March 1, 2021)
Amendment of Solicitation/Modification of Contract, Modification No. 3, entered into January 5, 2021, between the Company and the U.S. Department of Defense Joint Program... (NOVAVAX INC, Filed With SEC on March 1, 2021)